The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Insulin Infusion Systems

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Insulin Infusion Systems


High impact information on Insulin Infusion Systems


Biological context of Insulin Infusion Systems


Anatomical context of Insulin Infusion Systems


Associations of Insulin Infusion Systems with chemical compounds


Gene context of Insulin Infusion Systems


Analytical, diagnostic and therapeutic context of Insulin Infusion Systems


  1. Perfect normalization of excessive glucagon responses to intravenous arginine in human diabetes mellitus with the artificial beta-cell. Kawamori, R., Shichiri, M., Kikuchi, M., Yamasaki, Y., Abe, H. Diabetes (1980) [Pubmed]
  2. The effect of hyperglucagonemia on blood glucose concentrations and on insulin requirements in insulin-requiring diabetes mellitus. Clarke, W.L., Santiago, J.V., Kipnis, D.M. Diabetes (1978) [Pubmed]
  3. Circulating catecholamine and glucagon responses to insulin-induced blood glucose decrement in a patient with pheochromocytoma. Bolli, G., De Feo, P., Massi-Benedetti, M., Compagnucci, P., Cartechini, M.G., Santeusanio, F., Brunetti, P. J. Clin. Endocrinol. Metab. (1982) [Pubmed]
  4. Regulated production of mature insulin by non-beta-cells. Gros, L., Montoliu, L., Riu, E., Lebrigand, L., Bosch, F. Hum. Gene Ther. (1997) [Pubmed]
  5. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. Gutniak, M., Orskov, C., Holst, J.J., Ahrén, B., Efendic, S. N. Engl. J. Med. (1992) [Pubmed]
  6. Treatment with artificial beta-cell decreases very-low-density lipoprotein triglyceride synthesis in type I diabetes. Dunn, F.L., Carroll, P.B., Beltz, W.F. Diabetes (1987) [Pubmed]
  7. Closed-loop glycemic control with a wearable artificial endocrine pancreas. Variations in daily insulin requirements to glycemic response. Shichiri, M., Kawamori, R., Hakui, N., Yamasaki, Y., Abe, H. Diabetes (1984) [Pubmed]
  8. Transcription of the insulin gene: towards defining the glucose-sensitive cis-element and trans-acting factors. Melloul, D., Cerasi, E. Diabetologia (1994) [Pubmed]
  9. Effects of somatostatin added to insulin in a glucose-controlled insulin infusion system. Selam, J.L., Chenon, D., Pham, T.C., Gagnol, J.P., Sany, C., Thomas, N., Gravagne, G., Orsetti, A., Mirouze, J. Diabetologia (1981) [Pubmed]
  10. Restoration of fuel homeostasis in IDDM patients during pregnancy by an open-loop insulin infusion system. Foss, M.C., Aoki, T.T. Diabetes Care (1993) [Pubmed]
  11. Diabetes mellitus and open heart surgery. A simple, practical closed-loop insulin infusion system for blood glucose control. Watson, B.G., Elliott, M.J., Pay, D.A., Williamson, M. Anaesthesia. (1986) [Pubmed]
  12. Pancreatic beta-cells express a low affinity glucose transporter: functional consequences in normal and diabetic states. Marshall, M.O., Thomas, H.M., Seatter, M.J., Greer, K.R., Wood, P.J., Gould, G.W. Biochem. Soc. Trans. (1993) [Pubmed]
  13. Influence of insulin infusion kinetics of an artificial beta cell on blood glucose control in insulin-dependent diabetics. Kerner, W., Beischer, W., Maier, V., Pfeiffer, E.F. Horm. Metab. Res. Suppl. (1979) [Pubmed]
  14. Regulated production of mature insulin in rat hepatoma cells: insulin production is up-regulated by dexamethasone and down-regulated by insulin. Qin, X.Y., Shen, K.T., Song, L.J., Zhang, X., Han, Z.G. Acta Biochim. Biophys. Sin. (Shanghai) (2006) [Pubmed]
  15. Visualising insulin secretion. The Minkowski Lecture 2004. Rutter, G.A. Diabetologia (2004) [Pubmed]
  16. Effect of artificial pancreas treatment on peripheral nerve function in diabetes. Service, F.J., Daube, J.R., O'Brien, P.C., Dyck, P.J. Neurology (1981) [Pubmed]
  17. Feedback inhibition of insulin in healthy and overweight subjects studied by use of an artificial endocrine pancreas. Beischer, W., Schmid, M., Kerner, W., Keller, L., Pfeiffer, E.F. Horm. Metab. Res. Suppl. (1979) [Pubmed]
  18. Comparison between closed-loop portal and peripheral venous insulin delivery systems for an artificial endocrine pancreas. Sekigami, T., Shimoda, S., Nishida, K., Matsuo, Y., Ichimori, S., Ichinose, K., Shichiri, M., Sakakida, M., Araki, E. Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs. (2004) [Pubmed]
  19. Variation induced by a three-days application of the artificial beta-cell on glucagon, growth hormone and catecholamine secretion, glycosylated hemoglobin, and erythrocyte 2,3-diphosphoglycerate concentration. Brunetti, P., Massi-Benedetti, M., Puxeddu, A., Santeusanio, F., Calabrese, G., Bolli, G., Scionti, L., Angeletti, G. Horm. Metab. Res. Suppl. (1979) [Pubmed]
  20. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. Tamborlane, W.V., Sherwin, R.S., Genel, M., Felig, P. N. Engl. J. Med. (1979) [Pubmed]
  21. Reversal of D- and A-cell insensitivity to glucose in alloxan-diabetic dogs by treatment with the artificial beta cell (Biostator). Hermansen, K., Schmitz, O., Orskov, H. Diabetes (1985) [Pubmed]
  22. The role of "diabetogenic" hormones on carbohydrate and lipid metabolism following oral glucose loading in insulin dependent diabetics: effects of acute hormone administration. Bratusch-Marrain, P., Waldhäusl, W., Grubeck-Loebenstein, B., Korn, A., Vierhapper, H., Nowotny, P. Diabetologia (1981) [Pubmed]
  23. Implantable artificial capillary unit for pancreatic islet allograft and xenograft. Tze, W.J., Wong, F.C., Chen, L.M. Diabetologia (1979) [Pubmed]
  24. The effects of equal caloric amounts of xylitol, sucrose and starch on insulin requirements and blood glucose levels in insulin-dependent diabetics. Hassinger, W., Sauer, G., Cordes, U., Krause, U., Beyer, J., Baessler, K.H. Diabetologia (1981) [Pubmed]
  25. D-Trp8-D-Cys14-somatostatin--demonstration of its differential suppressive activity in juvenile diabetics. Neuhaus, C., Kerner, W., Maier, V., Pfeiffer, E.F. Horm. Metab. Res. Suppl. (1979) [Pubmed]
  26. Pancreatic polypeptide: a marker for lean non-insulin-dependent diabetes mellitus? Service, F.J., Koch, M.B., Jay, J.M., Rizza, R.A., Go, V.L. Diabetes Care (1985) [Pubmed]
  27. Attempts at perfect normalization of glucose tolerance test of severe diabetics by artificial beta cell. Kerner, W., Thum, C., Tamás, G., Beischer, W., Clemens, A.H., Pfeiffer, E.F. Horm. Metab. Res. (1976) [Pubmed]
  28. The evaluation of glucagon infusion algorithms for a counterregulatory system in artificial endocrine pancreas. Yagi, T., Yamasaki, Y., Bando, K., Kawamori, R., Kamada, T., Shichiri, M. Medical progress through technology. (1988) [Pubmed]
  29. Insulin treatment during diabetic coma with an artificial endocrine pancreas. Pfeiffer, E.F., Kerner, W., Beischer, W., Klier, M. Horm. Metab. Res. Suppl. (1979) [Pubmed]
  30. Effect of insulin replacement on intermediary metabolism in diabetes secondary to pancreatectomy. Del Prato, S., Tiengo, A., Baccaglini, U., Tremolada, C., Duner, E., Marescotti, M.C., Avogaro, A., Valverde, I., Nosadini, R., Assan, R. Diabetologia (1983) [Pubmed]
  31. Comparison of porcine insulin and human insulin (Novo) using the glucose-controlled insulin infusion system, glucose-insulin dose-response curves, and the outpatient effectiveness of human insulin (Novo) in insulin-dependent diabetes. Charles, M.A., Szekeres, A., Staten, M., Worcester, B., Walsh, K.M. Diabetes Care (1983) [Pubmed]
  32. Metabolic control during total parenteral nutrition: use of an artificial endocrine pancreas. Vigili de Kreutzenberg, S., Lisato, G., Riccio, A., Giunta, F., Bonato, R., Petolillo, M., Tiengo, A., Del Prato, S. Metab. Clin. Exp. (1988) [Pubmed]
  33. The antidiabetic action of somatostatin-28 as assessed by the artificial endocrine pancreas: greater potency than somatostatin-14. Hadjidakis, D.I., Raptis, S.A., Raptis, A.E., Karaiskos, C., Souvatzoglou, A., Diamantopoulos, E.J. Horm. Metab. Res. (1987) [Pubmed]
  34. Comparison of a perfusion syringe (Mill Hill Infusor) and a glucose-controlled insulin infusion system in the regulation of diabetes mellitus. Stavljenić, A., Granić, M., Topić, B., Skrabalo, Z. Horm. Metab. Res. Suppl. (1979) [Pubmed]
WikiGenes - Universities